Oxa(thia)zolidine compounds, process for preparation thereof and anti-inflammatory agents
申请人:——
公开号:US20040186096A1
公开(公告)日:2004-09-23
The present invention provides medicinal compositions characterized by comprising as the active ingredient either a compound represented by a formula [I] or a pharmaceutically acceptable composite thereof;
1
[wherein X represents oxygen or sulfur; R
1
represents e.g., C
1-4
alkyl, phenyl optionally substituted, etc.; Q
1
represents spacer consisted of 0 to 3 carbon atoms; R
2
represents, e.g., phenyl optionally substituted; R
3
represents, e.g., hydrogen, C
1-4
alkyl, or a group represented by the following formulae; —CONH—R
6
; R
4
and R
5
represent e.g., nitro, cyano, C
1-4
alkylcarbonyl, respectively];
in particular, medicine which is useful as therapeutic and/or protective drugs for inflammatory diseases and/or allergic diseases by improving sick conditions accompanied with the stimulated phospholipase A(2) activity.
本发明提供的药物组合物的特点是其活性成分为式[I]所表示的化合物或其药学上可接受的复合物;其中,X代表氧或硫;R1代表例如C1-4烷基,苯基可选取取代基等;Q1代表由0至3个碳原子组成的间隔基;R2代表例如苯基可选取取代基;R3代表例如氢,C1-4烷基或以下式表示的基团;—CONH—R6;R4和R5分别代表例如硝基,氰基,C1-4烷基羰基等;特别是,通过改善伴随磷脂酶A(2)活性刺激的病态条件,本发明提供的药物对于治疗和/或预防炎症性疾病和/或过敏性疾病非常有用。